Research led by Donald Sullivan, M.D., M.A., M.C.R., found use of noninvasive ventilation increased among Medicare beneficiates who were hospitalized within the last month of their life.

In a video interview, Derek C. Galligan M.D., discusses unmet needs in high-risk multiple myeloma.

A columnist describes recommendations about how to respond to a dementia diagnosis that she learned while attending a talk by Elizabeth Eckstrom, M.D., M.P.H., and Joe Quinn, M.D.

The life and accomplishments of former OHSU president Leonard Laster, M.D., are recalled.

The OHSU Knight Cancer Institute is one of three clinical trial sites to enroll patients in the first microbiome oncology therapeutic candidate from Genome & Company. Shivaani Kummar, M.D., says “Our goal is to learn more about whether this combination therapy will be effective in overcoming acquired resistance to anti-PD-(L)1 therapy in patients with advanced solid tumors whose disease has progressed on prior anti-PD-(L)1 therapy.”

Contemporary OB/GYN profiles the work of Aaron Caughey, M.D., Ph.D. prior to a presentation, at the ACOG 2020 Virtual Conference, regarding new developments in the timing of induced labor and maternal outcome.

The Oregonian reports on the life, accomplishments of former OHSU president Leonard Laster, M.D.

David Pollack, M.D., notes “The increased frequency and severity of extreme weather events around the world, such as hurricanes, wildfires, heatwaves, heavy precipitation, and air pollution result in anxiety, trauma, depression, worsening of psychosis, increased substance use, violence, and suicide.” Psychiatric News. In addition, OHSU contributed to Stanford University-led research that found caring for people’s health protects rainforests, slows climate change and creates significant monetary value.

A study in Nature Medicine demonstrates “superior” outcomes for patients with acute myeloid leukemia who participated in the Leukemia & Lymphoma Society’s “Beat AML” clinical trial. Brian Druker, M.D., is a leader of the national, multi-center effort and the OHSU Knight Cancer Institute is a top enroller of patients in the trial to date.

Judith Guzman-Cotrill, D.O., speaks on the need to continue public health guidelines during the holidays.